Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Peripheral Neurostimulation

5 de novembro de 2026 atualizado por: Jean-Louis Horn, Stanford University

Peripheral nerve blocks are routinely used and highly successful for intra-operative anesthesia and post-operative pain management. Nerve blocks are guided using either neurostimulation as a means to localize the right nerve or by ultrasound guidance or combining the 2 methods. The purpose of this study is to assess whether electrical stimulation improves nerve block quality, beyond its simple purpose of nerve localization.

Visão geral do estudo

Descrição detalhada

The investigators wish to understand how electrical stimulation can affect local anesthetic disposition when performing a peripheral nerve block.

By studying this subject, the investigators open possibilities for improvement on many levels:

increasing the efficacy of the nerve block allows for a reduced onset time, reduced incidence of incomplete block, and prolonged duration of the local anesthetics. This allows for patients to fully benefit from the analgesic properties of the nerve block, allows for a decrease in delays for the operating room readiness, and a allows for a decrease in the amount of medication needed for a successful nerve block. This will decrease side effects and risks of the nerve blocks. Overall better post-surgical pain control may decrease risks for developing chronic post-operative pain, a major post-operative complication.

The results of this study will open the door to novel approaches to manage acute post-operative pain.

Tipo de estudo

Intervencional

Inscrição (Estimado)

150

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • California
      • Stanford, California, Estados Unidos, 94305
        • Stanford University Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Undergoing elective upper limb surgery with a planned brachial plexus nerve block

Exclusion Criteria:

  • Under 18 years old
  • ASA score above III
  • Chronic pain condition with daily milligrams of morphine equivalent > 30
  • Poorly controlled psychiatric condition
  • Coagulopathy
  • Active infection
  • Moderate, severe or progressing neuropathy
  • COPD/Chronic oxygen user
  • Pregnancy
  • Incarceration
  • Unable to consent
  • BMI > 35
  • Pacemaker

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Dobro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Ultrasound-guided brachial plexus block with peripheral nerve stimulation

Patients will receive a brachial plexus catheter with ultrasound guidance as per standard of care, with additional use of the B. Braun HNS 12 nerve stimulator during the loading dose of local anesthesia to maintain a gentle twitch.

Nerve stimulator that is traditionally used for nerve localization during block placements.

Comparador Falso: Ultrasound-guided brachial plexus block without peripheral nerve stimulation

Patients will receive the brachial plexus catheter in the same way the first arm would, and the B Braun nerve stimulator will be placed in the same way, but the ground electrode will not be connected to the patient.

Stimulator will be placed and turned on, but the grounding electrode will not be connected to prevent nerve stimulation.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Onset of Motor Block
Prazo: Within 1 hour after the block placement.

Determining time when patient experiences first symptoms of local anesthetic action on the upper trunk distribution (median or musculo cutaneous nerve)

Within 1 hour after the block placement.
Onset of Sensory Block
Prazo: Within 1 hour after the block placement.

Determining time when patient experiences first symptoms of local anesthetic action on the superior trunk distribution over the shoulder.

Within 1 hour after the block placement.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Skin Temperature Change
Prazo: Immediately before and up to 1 hour after neurostimulation and nerve block is performed.

Measuring changes in skin temperature over the course of pre and post stimulation and nerve blocking between the blocked and unblocked arms, measured in degrees Celsius. Using Medline Temperature Sensor.

Immediately before and up to 1 hour after neurostimulation and nerve block is performed.
When Patient Experiences First Pain
Prazo: up to day 7 post operatively

Time after surgery at which the patient experiences first sign of pain at the surgical site, as measured by the time for first local anesthetic bolus based on pump device history.

up to day 7 post operatively
Time of First Opioid Taken
Prazo: Within the first 7 days after surgery

As measured by asking patients if they were taking opioids daily after surgery, up to one week.

Within the first 7 days after surgery
Total Post Operative MME/Opioid Usage at Day 1
Prazo: On Post Operative Day 1

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 1
Total Post Operative MME/Opioid Usage at Day 2
Prazo: On Post Operative Day 2

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 2
Total Post Operative MME Opioid Usage at Day 3
Prazo: On Post Operative Day 3

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 3
Total Post Operative MME Opioid Usage at Day 4
Prazo: On Post Operative Day 4

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 4
Total Post Operative MME Opioid Usage at Day 5
Prazo: On Post Operative Day 5

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 5
Total Post Operative MME Opioid Usage at Day 6
Prazo: On Post Operative Day 6

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 6
Opioid Usage Assessment at Day 7
Prazo: On Post Operative Day 7

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 7
Opioid Usage Assessment at Day 28
Prazo: On Post Operative Day 28

Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 3 weeks and 2) if so, how many pills per day.

On Post Operative Day 28
Opioid Usage Assessment at 6 Months
Prazo: On Post Operative Month 6

Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 5 months and 2) if so, how many pills per day.

On Post Operative Month 6
Opioid Usage Assessment at 1 Year
Prazo: On Post Operative 1 Year

Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 6 months and 2) if so, how many pills per day.

On Post Operative 1 Year
Quality of Recovery
Prazo: At Post Operative days 7 and 28 , 6 months, and 1 year

Using the standardized -Quality of Recovery 15- at post operative days 7 and 28, 6 months, and 1 year. Each item count on a 0-10 scale where 0 is worst and 10 is best.

PART A How have you been feeling in the last 24 hours? (0 to 10, where 0 = none of the time [poor] and 10 = all of the time [excellent]) Q.1 Able to breathe easily Q.2 Been able to enjoy food Q.3 Feeling rested Q.4 Have had a good sleep Q.5 Able to look after personal toilet and hygiene unaided Q.6 Able to communicate with family or friends Q.7 Getting support from hospital doctors and nurses Q.8 Able to return to work or usual home activities Q.9 Feeling comfortable and in control Q.10 Having a feeling of general well-being

PART B Have you had any of the following in the last 24 hours? (10 to 0, where 10 = none of the time [excellent] and 0 = all of the time [poor]) Q.11 Moderate pain Q.12 Severe pain Q.13 Nausea or vomiting Q.14 Feeling worried or anxious Q.15 Feeling sad or depressed

At Post Operative days 7 and 28 , 6 months, and 1 year
General satisfaction
Prazo: At post operative days 0, 1, 7, 28, 6 months, and 1 year

General satisfaction on a scale from 1-5 (extremely unsatisfied, unsatisfied, neutral, satisfy, extremely satisfied). Asking patients if they would receive the block again (Y/N).

At post operative days 0, 1, 7, 28, 6 months, and 1 year
Adverse Events
Prazo: Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.

Numbness, Weakness, Tingling, Breathing Difficulties, Hoarseness

Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.
Catheter Duration Before Discontinuation
Prazo: After surgery, up until catheter discontinuation.

Patients' catheter duration before discontinuation, as measured by Avoset pump device data.

After surgery, up until catheter discontinuation.
Total Local Anesthetic Use with Catheter
Prazo: After surgery, up until catheter discontinuation.

Patients' local anesthetic use with catheter, as measured by Avoset pump device data.

After surgery, up until catheter discontinuation.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

23 de julho de 2025

Conclusão Primária (Estimado)

30 de julho de 2027

Conclusão do estudo (Estimado)

30 de julho de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

7 de agosto de 2024

Enviado pela primeira vez que atendeu aos critérios de CQ

20 de agosto de 2024

Primeira postagem (Real)

22 de agosto de 2024

Atualizações de registro de estudo

Última Atualização Postada (Real)

10 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

5 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Sim

produto fabricado e exportado dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever